Accu-Joint® Hemi Implant System
Degenerative and post-traumatic arthritis of the MTP joint (Hallux Rigidus/Limitus)
ApprovedActive
Key Facts
Indication
Degenerative and post-traumatic arthritis of the MTP joint (Hallux Rigidus/Limitus)
Phase
Approved
Status
Active
Company
About Accufix Surgical
Accufix Surgical is a private, commercial-stage medical device company founded in 2015 and headquartered in San Diego, California. The company has developed and received FDA approval for the Accu-Joint® implant, a novel solution for big toe (MTP joint) arthritis that emphasizes bone preservation and resurfacing rather than bone resection and fusion. This approach aims to provide patients with reduced pain, faster recovery, maintained joint mobility, and preserved future surgical options. The company is now focused on commercializing this product to surgeons and patients as an alternative to the standard-of-care fusion procedure.
View full company profile